# Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects.

> **NCT00811798** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 92 (actual)

## Conditions studied

- Infections, Papillomavirus

## Interventions

- **BIOLOGICAL:** Cervarix

## Key facts

- **NCT ID:** NCT00811798
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2016-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00811798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00811798, "Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00811798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*